GLP insider files sale notice for 30,000 shares

GLP reported an intended sale of 30,000 common shares via Raymond James & Associates.

Rhea-AI Filing Summary

GLP reported an intended sale of 30,000 common shares via Raymond James & Associates.

The filing lists an aggregate offering price of $1,500,000.00 and shows 33,995,563 shares outstanding with an as of date of 03/09/2026. The excerpt also lists legacy phantom grant entries dated 02/26/2026 (12,170), 05/03/2025 (17,379), and 03/24/2025 (451).

Insights

Equity Markets Analyst

Routine Form 144 sale notice for 30,000 shares; administrative disclosure.

The filing shows an intended sale of 30,000 common shares through Raymond James & Associates with an aggregate amount of $1,500,000.00. Form 144 is a regulatory notice used to report proposed insider sales under Rule 144.

Transaction timing and execution details beyond the listing are not provided in the excerpt; subsequent public filings or broker reports would show actual sale execution or proceeds.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does GLP's Form 144 disclose about the insider sale?

The Form 144 discloses an intended sale of 30,000 common shares via Raymond James. It lists an aggregate offering price of $1,500,000.00 and an outstanding share count of 33,995,563 as of 03/09/2026.

Who is the broker handling the GLP transaction shown in the filing?

The filing identifies Raymond James & Associates at 880 Carillon Parkway, St. Petersburg, FL, as the broker. The excerpt pairs the broker name with the listed sale quantity of 30,000 shares.

Are the phantom grants listed in GLP's Form 144 part of the sale amount?

The excerpt lists three phantom grant entries with dates and counts (12,170; 17,379; 451). These entries are shown in the securities section but the filing does not explicitly say they are included in the 30,000 sale amount.

Does the Form 144 confirm the sale has been executed for GLP?

No; the Form 144 in the excerpt reports the intended sale quantity and related figures. It does not provide confirmation of execution or settlement details—those would appear in subsequent transaction reports or broker records.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/09/2026 - 04:19 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001578638
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	GLOBAL PARTNERS LP
SEC File Number	001-32593
Address of Issuer	P.O. BOX 9161 800 SOUTH STREET, SUITE 500 WALTHAM MASSACHUSETTS 02454
Phone	(781) 894-8800
Name of Person for Whose Account the Securities are To Be Sold	Romaine Mark
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Raymond James & Associates 880 Carillon Parkway St. Petersburg FL 33716	30000	1500000.00	33995563	03/09/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/26/2026	Phantom Grant	Issuer			12170	02/26/2026	Compensation
Common	05/03/2025	Phantom Grant	Issuer			17379	05/03/2025	Compensation
Common	03/24/2025	Phantom Grant	Issuer			451	03/24/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	03/09/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Maressia Rooks-Bailey, as duly authorized representative of Raymond James & Associates, Inc., as attorney-in-fact for Mark Romaine
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)